“The North Coast, particularly Ras al-Hikma, has seen substantial investments, including a $35 billion development agreement ...

The Egyptian government is finalizing the investment blueprint for the Ras Banas region on the Red Sea in an effort to ...

Madbouly's announcement comes a day after CEO of the General Authority for Investment and Free Zones (GAFI) Hossam Heiba said the Ras El-Hikma deal “may exceed $22 billion." The PM stressed that ...

Hikma is offering clindamycin in 5% dextrose injection, in 300mg/50ml, 600mg/50ml and 900mg/50ml doses. The product is available in a vial. Clindamycin in 5% dextrose injection is indicated for ...

Hikma has completed its acquisition of Xellia Pharmaceuticals’ U.S. finished dosage form business and related assets following clearance under applicable U.S. antitrust laws. The acquisition ...

Aug 27 (Reuters) - Drug companies Jazz (JAZZ.O), opens new tab and Hikma (HIK.L), opens new tab must face claims that they schemed to delay a generic version of Jazz’s blockbuster narcolepsy ...

Abdullah bin Touq Al Marri Minister of Economy held bilateral meetings with Lieutenant General Kamel El Wazir Deputy Prime ...

Moreover, El-Sherbiny received detailed updates on the progress of utility and road projects in "Shams Al-Hikma," a ...

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics ...

Hikma Pharmaceuticals PLC HIK shares inched up 0.88% to £19.53 Monday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.06% to ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million ...

Hikma Pharmaceuticals PLC HIK shares inched up 0.82% to £19.77 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.35% ...